Cytomegalovirus infection-enhanced chronic rejection in the rat is prevented by antiviral prophylaxis.
Tikkanen
J
J
Transplantation Laboratory, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Kallio
E
E
Pulkkinen
V
V
Bruggeman
C
C
Koskinen
P
P
Lemström
K
K
D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D003251:Constriction, Pathologic / Q000209:etiology / Q000517:prevention & control; D003586:Cytomegalovirus Infections / Q000150:complications* / Q000517:prevention & control; D015774:Ganciclovir / Q000627:therapeutic use*; D006084:Graft Rejection / Q000209:etiology / Q000517:prevention & control*; D007116:Immunization, Passive; D007136:Immunoglobulins / Q000627:therapeutic use*; D016756:Immunoglobulins, Intravenous; D051381:Rats; D014132:Trachea / Q000637:transplantation*; D014133:Tracheal Diseases / Q000209:etiology / Q000517:prevention & control*
D000998:Antiviral Agents; D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous; C045781:cytomegalovirus-specific hyperimmune globulin; D015774:Ganciclovir